From: Covid-19 and gender: lower rate but same mortality of severe disease in women—an observational study
N | All patients (N = 431) | Gender | |||
---|---|---|---|---|---|
Female (N = 119) | Male (N = 312) | p | |||
Pre-hospital antibiotica—no. (%) | 384 | 192 (50.0) | 49 (45.4) | 143 (51.8) | 0.26 |
Contact with healthcare facilities in the last 14 daysb—no. (%) | 380 | 125 (32.9) | 40 (36.4) | 85 (31.5) | 0.36 |
Contact with minors in the last 14 days—no. (%) | 271 | 99 (36.5) | 33 (41.8) | 66 (34.4) | 0.25 |
Family membersc, median [IQR] | 295 | 2.0 [2.0–3.0] | 2.0 [2.0–3.0] | 2.0 [2.0–3.0] | 0.85 |
Family member with confirmed Covid-19—no. (%) | 296 | 45 (15.2) | 15 (17.6) | 30 (14.2) | 0.46 |
Contact with Covid-19 confirmed case—no. (%) | 317 | 81 (25.6) | 21 (22.6) | 60 (26.8) | 0.43 |
Healthcare professional—no. (%) | 380 | 27 (7.1) | 8 (7.5) | 19 (7.0) | 0.86 |
Symptomsd—no. (%) | |||||
Fever | 425 | 383 (90.1) | 107 (90.7) | 276 (89.9) | 0.81 |
Cough | 424 | 213 (50.2) | 62 (52.5) | 151 (49.3) | 0.56 |
Dyspnoea | 425 | 252 (59.3) | 68 (57.6) | 184 (59.9) | 0.66 |
Sore throat | 424 | 13 (3.1) | 6 (5.1) | 7 (2.3) | 0.20 |
Dizziness | 424 | 18 (4.2) | 9 (7.6) | 9 (2.9) | 0.032 |
Abdominal pain | 424 | 10 (2.4) | 5 (4.2) | 5 (1.6) | 0.11 |
Chest pain | 424 | 15 (3.5) | 3 (2.5) | 12 (3.9) | 0.49 |
Systemic (asthenia, myalgia) | 424 | 137 (32.3) | 45 (38.1) | 92 (30.1) | 0.11 |
Gastrointestinale | 424 | 77 (18.2) | 29 (24.6) | 48 (15.7) | 0.033 |